Practices, Challenges, and Opportunities to Improving Pneumococcal Immunization in Working-Age, At-Risk Adults Through Community Pharmacies

Infectious Diseases in Clinical Practice

Volumn 25, Issue 1, 2017, Pages 23-28

  Kulczycki, Andrzej ^a   Wensel, Terri M ^b   Hogue, Michael ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SAMFORD UNIVERSITY   (United States)

Author keywords

Community pharmacy; Immunization barriers; Pneumococcal vaccination; Vaccine education

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; AWARENESS; CLINICAL PRACTICE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PRACTICE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; IMMUNIZATION; INFECTION RISK; INTERPERSONAL COMMUNICATION; KNOWLEDGE; MALE; MASS MEDIUM; PATIENT ADVOCACY; PATIENT EDUCATION; PATIENT INFORMATION; PHARMACIST; PHARMACIST ATTITUDE; PNEUMOCOCCAL INFECTION; PUBLIC-PRIVATE PARTNERSHIP; SEMI STRUCTURED INTERVIEW; SOFTWARE; WORK CAPACITY; WORK EXPERIENCE;

EID: 84991475230     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0000000000000452     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (CDC). Pneumococcal disease. In: Atkinson W, Wolfe C, Hamborsky J, eds. , 13th ed. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington, DC: Public Health Foundation; 2015:e279-e295.
2. Huang SS, Johnson KM, Ray GT, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29(18):3398-3412.
3. Willis BC, Ndiaye SM, Hopkins DP, et al. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged 65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep, 2005, 54, RR-5, 1-11
4. PNEUMOVAX 23 (pneumococcal vaccine polyvalent) sterile, liquid vaccine for intramuscular or subcutaneous injection-prescribing information. Available at: http://www. merck. com/product/usa/pi-circulars/p/pneumovax-23/pneumovax-pi. pdf. Accessed May24, 2016.
5. PREVNAR 13 prescribing information. Available at: http://www. fda. gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm201669. pdf. Accessed May24, 2016.
6. CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb MortalWkly Rep. 2012;61(40):816-819.
7. Tomczyk S, BennettNM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ?65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(37):822-825.
8. File TM. Pneumococcal vaccination remains a high priority. Infect Dis Clin Pract. 2016;24(1):1-2.
9. Kim DK, Bridges CB, Harriman KH. Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2016. Ann Intern Med. 2016;164(3):184-194.
10. Williams WW, Lu PJ, O'Halloran A, et al. Surveillance of vaccination coverage among adult populations-United States, 2014. MMWR Surveill Summ. 2016;65(1):1-36.
11. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020. Available at: https://www. healthypeople. gov/. Accessed March 4, 2016.
12. NFID (National Foundation for Infectious Diseases). Pneumococcal disease. Available at: http://www. adultvaccination. com/pneumococcal-vaccine-vaccination-adult-immunization. htm. Accessed April 2, 1014.
13. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7 suppl 2):S28-S35.
14. Harris KM, Uscher-Pines L, Mattke S, et al. A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States, Santa Monica, CA: RAND Corporation, TR-1169-GSK. 2011.
15. Hogue MD, Grabenstein JD, Foster SL, et al. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2006;46(2):168-181.
16. Rothholz MC. The role of community pharmacies/pharmacists in vaccine delivery in the United States. American Pharmacists Association. 2013 Available at: http://www. cdc. gov/vaccines/acip/meetings/downloads/slides-jun-2013/01-Pharmacies-Rothholz. pdf. Accessed March 20, 2014.
17. Goad JA, Taitel MS, Fensterheim LE, et al. Vaccinations administered during off-clinic hours at a national community pharmacy: Implications for increasing patient access and convenience. Ann Fam Med. 2013;11(5): 429-436.
18. Alabama Department of Public Health. Primary Care Health Professional Shortage Areas, May 2015. Available at: http://adph. org/ruralhealth/assets/Primary-Care-HPSA-Map. pdf. Accessed April 30, 2016.
19. Xu JQ, Murphy SL, Kochanek KD, et al. Deaths: final data for 2013. Natl Vital Stat Rep; 64(2):1-96. Hyattsville, MD: National Center for Health Statistics. 2016. Accessed April 30, 2016, from http://www. cdc. gov/nchs/data/nvsr/nvsr64/nvsr64-02. pdf.
20. Alabama Department of Public Health. Unpublished statistics, personal communication with Bonnie Davis, Registry Branch Director, Immunization Division, May 27, 2016.
21. Taitel M, Cohen E, Duncan I, et al. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations. Vaccine. 2011;29(45):8073-8076.
22. Westrick SC, Owen J, Hagel H, et al. Thanasak Lertpichitkul Impact of the RxVaccinate program for pharmacy-based pneumococcal immunization: A cluster-randomized controlled trial. J Am Pharm Assoc. 2016;56(1):29-36.
23. American Pharmacists Association. Pharmacy-based immunization delivery. Available at: http://www. pharmacist. com/pharmacy-basedimmunization-delivery. Accessed May 30, 2016.
24. CDC. Letter to the pharmacy community from the Principal Deputy Director, CDC, received by the American Pharmacy Association, September 28, 2015. Available at: https://www. pharmacist. com/sites/default/files/files/CDC%20letter%20to%20pharmacists%20vaccinators. pdf. Accessed August 14, 2016.
25. Corbin J, Strauss AL. Basics of Qualitative Research: Techniques and Procedures and Techniques for Developing Grounded Theory. 4th ed. Thousand Oaks, CA: Sage; 2015.
26. U. S. Department of Health & Human Services. The Affordable Care Act and Immunization, January 20, 2012. Available at: http://www. hhs. gov/healthcare/facts-and-features/fact-sheets/aca-and-immunization/index. html. Accessed August12, 2016.
27. Tian LJ. Vaccine Financing, the Affordable Care Act (ACA), and Immunizations. Paper presented at the National Adult and Influenza Immunization Summit, May 2015. Available at: http://www. izsummitpartners. org/wp-content/uploads/2015/05/Pre-a-2-Tan-Vaccine-Financing. pdf. Accessed August 12, 2016.